AR087540A1 - NON-RESIDUAL VETERINARY COMPOSITIONS ABOVE (POUR-ON), USE, KIT AND METHOD OF PARASITOSIS TREATMENT - Google Patents

NON-RESIDUAL VETERINARY COMPOSITIONS ABOVE (POUR-ON), USE, KIT AND METHOD OF PARASITOSIS TREATMENT

Info

Publication number
AR087540A1
AR087540A1 ARP120102981A ARP120102981A AR087540A1 AR 087540 A1 AR087540 A1 AR 087540A1 AR P120102981 A ARP120102981 A AR P120102981A AR P120102981 A ARP120102981 A AR P120102981A AR 087540 A1 AR087540 A1 AR 087540A1
Authority
AR
Argentina
Prior art keywords
parasitosis
treatment
pour
kit
veterinary compositions
Prior art date
Application number
ARP120102981A
Other languages
Spanish (es)
Inventor
Billi Maurizio
Original Assignee
Eurofarma Lab S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurofarma Lab S A filed Critical Eurofarma Lab S A
Publication of AR087540A1 publication Critical patent/AR087540A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Composiciones veterinarias útiles para el tratamiento de parasitosis en animales, particularmente rebaños lecheros, que comprenden avermectinas y excipientes específicos aceptables para veterinaria. La presente trata también de usos de dichas composiciones, kits y método mejorado para el tratamiento de parasitosis en animales.Veterinary compositions useful for the treatment of parasitosis in animals, particularly dairy herds, comprising avermectins and specific excipients acceptable to veterinarians. This is also about uses of said compositions, kits and improved method for the treatment of parasitosis in animals.

ARP120102981A 2011-08-25 2012-08-14 NON-RESIDUAL VETERINARY COMPOSITIONS ABOVE (POUR-ON), USE, KIT AND METHOD OF PARASITOSIS TREATMENT AR087540A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI1104180-3A BRPI1104180A2 (en) 2011-08-25 2011-08-25 veterinary compositions for waste disposal, use, kit, and method of treating parasitic diseases

Publications (1)

Publication Number Publication Date
AR087540A1 true AR087540A1 (en) 2014-04-03

Family

ID=47745787

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120102981A AR087540A1 (en) 2011-08-25 2012-08-14 NON-RESIDUAL VETERINARY COMPOSITIONS ABOVE (POUR-ON), USE, KIT AND METHOD OF PARASITOSIS TREATMENT

Country Status (4)

Country Link
AR (1) AR087540A1 (en)
BR (1) BRPI1104180A2 (en)
UY (1) UY34289A (en)
WO (1) WO2013026117A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107787963A (en) * 2017-07-03 2018-03-13 齐鲁制药（内蒙古）有限公司 A kind of preparation method of anti-caking AVM toluene ointment

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
AU2006100661B4 (en) * 2006-05-15 2006-09-07 Wyeth Topical formulation
WO2009005513A1 (en) * 2007-06-29 2009-01-08 Y-Tex Corporation Pesticidal ear tag
NZ585499A (en) * 2007-11-26 2011-12-22 Merial Ltd Solvent systems for pour-on formulations for combating parasites
GB201021836D0 (en) * 2010-12-21 2011-02-02 Norbrook Lab Ltd Topical Composition

Also Published As

Publication number Publication date
UY34289A (en) 2013-04-05
WO2013026117A1 (en) 2013-02-28
BRPI1104180A2 (en) 2013-08-13

Similar Documents

Publication Publication Date Title
CL2015003801A1 (en) Antibody formulations and methods
DOP2016000109A (en) SOLID FORMS OF ACID {[5- (3-CHLOROPHENYL) -3-HYDROXIPIRIDIN-2-CARBON] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME.
DOP2016000107A (en) PIRROLO [1,2-f] [1,2,4] USEFUL TRIAZINS TO TREAT INFECTIONS BY THE RESPIRATORY SYNCTIAL VIRUS.
CR20150610A (en) PIRIMIDINE COMPOUNDS REPLACED AND DERIVATIVES TO COMBAT ANIMAL PESTS
CL2013000077A1 (en) Use of 1 ′ substituted ribose derived compounds comprising pyrrolo [1,2-f] [1,2,4] triazine nucleobases to treat paramyxoviridae infections; 1 'substituted ribose derived compounds comprising pyrrolo [1,2-f] [1,2,4] triazine nucleobases; and pharmaceutical composition that includes them.
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
UY32923A (en) POLYCHYCLICAL COMPOUNDS AS ANTAGONISTS OF THE LISOPHOSPHATIDIC ACID RECEPTOR
ECSP14006132A (en) BENZOTHIAZOLE-6-IL ACETIC ACID DERIVATIVES AND THEIR USE TO TREAT HIV INFECTION
CR11731A (en) COMPOSITIONS AND PROCEDURES FOR PREPARATION AND USE
ECSP11011113A (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
CL2009001032A1 (en) Combinations of active compounds to control animal pests; use of combinations; and procedures to control animal pests.
CL2011000986A1 (en) Halosubstituted compounds; use of said compounds to combat animal pests; procedure for the preparation of phytoprotectors; procedure to fight pests; and intermediary compounds.
CR20120264A (en) COMPOUNDS
GT201300080A (en) ELABORATION PROCESS FOR PIRIMIDINE DERIVATIVES
UY32502A (en) ANTIHELMINTIC AGENTS AND ITS USE
BR112015018270A2 (en) compositions comprising 15-ohepa and methods of using them
CR20160235A (en) TIENOPIRIMIDINS AS MKNK1 AND MKNK2 INHIBITORS
EA201690323A1 (en) METHODS OF TREATING EAR DISEASES IN CHILDREN
GT201700220A (en) USEFUL PIRAZOL DERIVATIVES AS INHIBITORS OF 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP)
CU20170086A7 (en) PIRAZOLPIRIDINAMINS AS INHIBITORS OF MKNK1 AND MKNK2
MX364800B (en) Improved long-acting tilmicosin and use thereof in the treatment of bovine respiratory disease complex (brdc) and in the dry cow period.
CL2015001448A1 (en) Method for synchronization of insemination time in young sows
UY31717A1 (en) (PIRAZOLILCARBONIL) IMIDAZOLIDINONES REPLACED AND ITS USE
CR20160432A (en) WNT SIGNALING ROAD INHIBITORS
UY37444A (en) SUBSTITUTED DERIVATIVES OF 6- (1H-PIRAZOL-1-IL) PIRIMIDIN-4-AMINA AND ITS USE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal